A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04495933 |
|
Recruitment Status :
Recruiting
First Posted : August 3, 2020
Last Update Posted : September 4, 2020
|
Sponsor:
The University of Queensland
Collaborators:
Syneos Health
Coalition of Epidemic Preparedness Innovations (CEPI)
Information provided by (Responsible Party):
The University of Queensland
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2020 |
| Estimated Study Completion Date : | September 2021 |